Centaurus Financial, Inc. Repligen Corp Transaction History

Centaurus Financial, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$247.59 - $304.47 $144,840 - $178,114	-585 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $113,940 - $189,662	585 New	585 $169,000
Q3 2019 Nov 12, 2019	SELL	$76.65 - $95.51 $115,434 - $143,838	-1,506 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$54.2 - $85.95 $81,625 - $129,440	1,506 New	1,506 $129,000
Q3 2018 Nov 05, 2018	SELL	$46.8 - $58.97 $70,434 - $88,749	-1,505 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$35.26 - $47.04 $53,066 - $70,795	1,505 New	1,505 $71,000

477

54.9M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.66B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.